DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Pharmaceutical

DURECT

DURECT's headquarters in Cupertino, CA, United States

James E. Brown

Charlie Claycomb

Timothy M. Papp

Weiqi Lin

Judy Joice

Judith J. Robertson

Peter Garcia

Terrence F. Blaschke

Gail M. Farfel

Gail J. Maderis

This department oversees the strategic direction and governance of the organization through board leadership and membership.

Board Governance

The Director Team at DURECT is responsible for strategic oversight and leadership across various functions, including contracts, IT, engineering, manufacturing development, clinical packaging, EHS, security, and corporate facilities. Their main objective is to align the company’s operations with its mission to advance novel therapies for acute and chronic liver diseases.

Director Team

This department manages financial transactions, including accounts payable and overall financial reporting.

Accounting Department

This department focuses on the advancement and management of clinical research and development processes.

Clinical Development

This department provides overall strategic direction and leadership for the organization.

Executive Leadership

This department oversees the management and implementation of technology systems and data infrastructure.

DURECT

Org chart

Board & advisors

Teams

Board Governance

Director Team

Accounting Department

Clinical Development

Executive Leadership

Information Technology

Offices

DURECT

Org chart

Board & advisors

Teams

Board Governance

Director Team

Accounting Department

Clinical Development

Executive Leadership

Information Technology

Offices

Related companies